The world’s first patented health technology to help protect healthy cell growth – naturally

Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths globally in 2020. The cancer pandemic is still increasing, with the most frequent organs of origin being breast, lung, colon and prostate.

In healthy tissues, the replacement of old cells by the growth of new ones is precisely regulated. Thus, the total number of cells in our body and organs remains essentially unchanged. In cancer, this tight regulation is lost. Mutations in the DNA software of a cell turns this cell immortal and leads to its incessant multiplication, forming tumors.

Cancer cells then invade neighboring body tissue and – via the blood and lymphatic system – eventually spread to other parts of the body, a process called metastasis. Most cancer patients do not die from primary tumors, but rather during the metastatic stage of the disease. Thus, inhibiting the spread of cancer cells is a primary target towards cancer control.

Conventional medicine is largely confined to treating the symptoms of cancer. These treatments usually include surgical removal of tumors followed by an attempt to kill migrating cancer cells using radiation (radiotherapy) and/or toxic chemicals (chemotherapy). Both these methods kill not only cancer cells, but also healthy cells, in particular the rapidly dividing immune cells. These extremely toxic treatments can cause organ damage, impair immune defense, and trigger new cancers.

These conventional therapies do not address the cellular malfunctions underlying the cancer process. These crude conventional cancer therapies are the primary reason why – after more than a century of pharmaceutical research – cancer continues in pandemic proportions.

Our modern understanding of the cellular basis of cancer involves natural compounds that can correct and regulate biological processes in cancer cells without damaging healthy cells. One key target is the natural blocking of the very mechanism that all cancer cells use to spread in the body.

While cancer can be caused by many factors, its growth and spread in the body involves disease mechanisms common to all types of cancer. The expansion of tumor cells into the surrounding tissue (invasion), as well as their metastatic spread, requires the digestion of connective tissue.

Thus, all cancer cells produce biological scissors (enzymes) that pave the way for cancer cells to migrate through the body. The more of these enzymes a cancer cell produces, the more aggressive (malignant) is the cancer, and the shorter is the life expectancy of the patient.

Cellular control of the cancer process naturally, supported by a patent

At the Dr. Rath Research Institute, we tested a multitude of micronutrients and their combinations for their efficacy in helping to block various aspects of cancer cell growth and spread. This comprehensive research resulted in the first patented ‘method for treatment of neoplastic diseases’, based entirely on natural compounds. The term ‘neoplastic diseases’ is a technical term for cancer used in patents.

The efficacy of this natural health technology was confirmed in more than 55 types of human cancer cells. Moreover, our research identified key cancer mechanisms that can be simultaneously inhibited at the cellular level by these micronutrients, including:

1. Inhibiting the multiplication of cancer cells.

2. Inhibiting tumor growth.

3. Inhibiting invasive and metastatic spread of tumor cells.

4. Inhibiting the excessive growth of new blood vessels that supply blood to the growing tumor (angiogenesis).

5. Inducing the selective death of cancer cells, while leaving healthy cells unaffected, by inducing a ‘suicide program’ inside cancer cells (apoptosis).

This unique combination of micronutrients was able to inhibit all key biological processes related to the development and spread of cancer cells — naturally and without side effects.

Download overview of
Dr Rath Research Institute –
Scientific Publications – Cancer

Micronutrient combinations help to protect healthy cell growth

Figure 1 and 2: The patented micronutrient combination can inhibit the growth (proliferation) of various types of human cancer cells. Figure 1: breast cancer cells; figure 2: colon cancer cells. EGCG = epigallocatechin gallate (green tea extract), ascorbic acid = vitamin C.

What is the difference from a pharmaceutical drug patent?